PIA
PGEN icon

Piedmont Investment Advisors’s Precigen PGEN Stock Holding History

Piedmont Investment Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,207
Closed -$17K – 1938
2018
Q2 		$17K Buy
+1,207
New +$20.4K ﹤0.01% 1635

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Piedmont Investment Advisors's PGEN Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Precigen (PGEN) in Q3 2018, closing a stake of 1,207 shares — an estimated $17K sold.

Piedmont Investment Advisors first reported a position in PGEN in Q2 2018 and held it in 1 quarter. The position peaked at $17K in Q2 2018. 170 funds tracked by Wall St. Rank hold PGEN as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Precigen position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 1,207 Precigen shares in Q3 2018, an estimated $17K.
  • Piedmont Investment Advisors first reported a position in Precigen in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Precigen position peaked at $17K in Q2 2018.
  • 170 funds tracked by Wall St. Rank held Precigen as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.